Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02753283 · ClinicalTrials.gov registry record · Phase 4
Preventing Osteoporosis Using Denosumab
A Phase 4 study, sponsored by Susan L. Greenspan.
- Completed
- Registry status
- Phase 4
- Development phase
- 201
- Enrollment target
NCT02753283: Completed Phase 4 study, sponsored by Susan L. Greenspan.
NCT02753283 is a Phase 4 study that has completed, run by Susan L. Greenspan. The registered enrollment target is 201 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02753283, a Phase 4 study, has completed, sponsored by Susan L. Greenspan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 201 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out if denosumab (Prolia®), an injection given in the arm under the skin every 6 months, works to treat bone loss and prevent it from worsening in older men and women (ages 65 and older) who have osteoporosis and reside in long-term care (LTC) facilities.
Primary Outcome
Bone Mineral Density (BMD) of the total hip percent change over 24 months as assessed by dual-energy x-ray absorptiometry (DXA)
Interventions
- DRUG Placebo
- DRUG denosumab
- DIETARY_SUPPLEMENT Calcium and Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2016-06 |
| Est. Completion | 2023-08 |
| Phase | Phase 4 |
What the finished NCT02753283 record still lists
NCT02753283 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02753283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02753283 about?
NCT02753283 is a clinical study titled "Preventing Osteoporosis Using Denosumab". The purpose of this research study is to find out if denosumab (Prolia®), an injection given in the arm under the skin every 6 months, works to treat bone loss and prevent it from worsening in older men and women (ages 65 and older) who have osteoporosis and reside in long-term care (LTC) facilities...
What is the current status of trial NCT02753283?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 201 participants. The study started on 2016-06. Estimated completion is 2023-08.
What interventions are being tested in trial NCT02753283?
The interventions under investigation include: Placebo (DRUG), denosumab (DRUG), Calcium and Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02753283?
This trial is sponsored by Susan L. Greenspan, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02753283's enrollment target sits among peer trials
201 406th of 2000 higher than 1,594 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia